Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-31 Purchase(A) |
2025-04-08 7:05 pm |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
1,240 | $24.15 | $29,943 | 1,240 (Direct) |
View |
2025-03-31 Purchase |
2025-04-02 6:29 pm |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
1,240 | $24.15 | $29,943 | 1,240 (Direct) |
View |
2024-10-25 Sale |
2024-10-25 7:28 pm |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
11,000 | $80.89 | $889,790 | 11,000 (Direct) |
View |
2024-02-08 Sale |
2024-02-08 7:38 pm |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
25,000 | $28.05 | $701,250 | 0 (Direct) |
View |
2024-01-19 Sale |
2024-01-19 8:35 pm |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
30,000 | $23.05 | $691,500 | 25,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-02 Option Award |
2025-01-06 8:11 pm |
2026-01-02 2035-01-02 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
18,800 | $0 | 18,800 (Direct) |
View |
2024-10-25 Exercise |
2024-10-25 7:28 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
11,000 | $0 | 11,000 (Direct) |
View |
2024-10-25 Exercise |
2024-10-25 7:28 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
11,000 | $4.88 | 11,000 (Direct) |
View |
2024-02-08 Exercise |
2024-02-08 7:38 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
25,000 | $8.32 | 0 (Direct) |
View |
2024-02-08 Exercise |
2024-02-08 7:38 pm |
2020-07-01 2029-07-01 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
25,000 | $0 | 0 (Direct) |
View |
2024-01-19 Exercise |
2024-01-19 8:35 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
30,000 | $8.32 | 25,000 (Direct) |
View |
2024-01-19 Exercise |
2024-01-19 8:35 pm |
2020-07-01 2029-07-01 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
30,000 | $0 | 25,000 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 9:25 pm |
2025-01-02 2034-01-02 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
32,000 | $0 | 32,000 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 6:11 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
22,000 | $0 | 22,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 7:10 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
22,000 | $0 | 22,000 (Direct) |
View |
2021-06-30 Option Award |
2021-07-07 5:46 pm |
N/A N/A |
NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rouan Sarah Kathryn Director |
4,892 | $0 | 18,242 (Direct) |
View |
2021-01-13 Option Award |
2021-01-14 4:38 pm |
2022-01-13 2031-01-13 |
NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rouan Sarah Kathryn Director |
2,500 | $0.001 | 15,850 (Direct) |
View |
2021-01-04 Option Award |
2021-01-06 4:38 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
22,000 | $0 | 22,000 (Direct) |
View |